Sally C. Pipes
Commentary
The Culprit Impeding Drug Competition Is Not Who The Feds Expected
The Federal Trade Commission and U.S. Department of Justice recently kicked off a series of listening sessions to examine barriers to competition in the drug industry. The title of the first session—”Anticompetitive Conduct by Pharmaceutical Companies”—made it seem that regulators would chiefly investigate biotech firms. Yet by the end, panelists ...
Commentary
No, Donald Trump didn’t just slash Medicaid
Republicans’ One Big Beautiful Bill Act is now law. Democrats have wasted no time accusing the GOP of enshrining devastating “cuts” to Medicaid, the joint federal-state entitlement that provides health coverage for low-income Americans. That’s rubbish. The measure takes steps to restrain Medicaid’s rampant growth in recent years so that ...
Commentary
Cheap Drugs from Canada Can’t Make America Healthy
The U.S. Food and Drug Administration just announced plans to help states and Indian tribes purchase certain prescription drugs from Canada, where brand-name medicines tend to be cheaper because the government caps their price. The new guidance is part of a larger Trump administration effort to cut drug prices for ...
Commentary
As PBMs Drive Up Drug Prices, Silence Is Not Golden
The Trump administration has been mum in recent weeks on its “most favored nation” drug pricing plan, which broadly aims to link U.S. prices for medicines to the lowest prices in other developed countries. It’s unclear what those prices will be, how they’ll be determined, or how the administration will ...
Commentary
A Promising New AIDS Drug Highlights The Dangers Of Price Controls
The U.S. Food and Drug Administration approved a shot last month that effectively prevents HIV. At-risk people simply need to receive the injection every six months. The new drug, called lenacapavir, comes almost exactly 44 years after the first case of AIDS was reported by what’s now known as the ...
Commentary
Let the Message Be Clear: Canadian Healthcare Failed
Meet Mary, a 60-year-old woman from British Columbia. She needed a colonoscopy to confirm her cancer diagnosis. Mary spent four months on a waiting list. Then her bowel ruptured, and she suffered life-threatening sepsis. Due to the delay in treating her cancer, she had to get chemotherapy, which came with ...
Commentary
Trump tackles waste, fraud, and abuse in Obamacare
The Trump administration earlier this month finalized a rule that aims to stop waste, fraud, and abuse in the federally subsidized Obamacare exchanges. It’s about time. Millions of people who don’t qualify for free health coverage are receiving it on the public’s dime. The new rule will restore some measure ...
Commentary
Democrats Should Be Honest About Healthcare Waste and Fraud
For weeks, opponents of Republicans’ One Big Beautiful Bill Act have portrayed it as a threat to health coverage for millions of Americans. Some critics have said that it would covertly repeal Obamacare. If only. The bill is hardly a radical assault on health coverage. It would finally crack down ...
Commentary
Congress Can Help Small Businesses Afford Health Insurance
Health insurance is more expensive than ever. The average family plan last year cost employers and employees over $19,000 and nearly $6,300 per year, respectively. That’s enough to buy a new car. Congressional Republicans’ budget reconciliation bill could help bring down those costs. Among other things, the One Big Beautiful ...
Commentary
Physician-Assisted Suicide Is A Bigger Problem Than We Realize
Dovie Eisner was born with a rare genetic condition called nemaline myopathy. He requires a wheelchair and has a host of other health problems. Last year at one point, he stopped breathing, passed out on the street, and was taken to the emergency room. “I was alive—thanks to the determination ...
The Culprit Impeding Drug Competition Is Not Who The Feds Expected
The Federal Trade Commission and U.S. Department of Justice recently kicked off a series of listening sessions to examine barriers to competition in the drug industry. The title of the first session—”Anticompetitive Conduct by Pharmaceutical Companies”—made it seem that regulators would chiefly investigate biotech firms. Yet by the end, panelists ...
No, Donald Trump didn’t just slash Medicaid
Republicans’ One Big Beautiful Bill Act is now law. Democrats have wasted no time accusing the GOP of enshrining devastating “cuts” to Medicaid, the joint federal-state entitlement that provides health coverage for low-income Americans. That’s rubbish. The measure takes steps to restrain Medicaid’s rampant growth in recent years so that ...
Cheap Drugs from Canada Can’t Make America Healthy
The U.S. Food and Drug Administration just announced plans to help states and Indian tribes purchase certain prescription drugs from Canada, where brand-name medicines tend to be cheaper because the government caps their price. The new guidance is part of a larger Trump administration effort to cut drug prices for ...
As PBMs Drive Up Drug Prices, Silence Is Not Golden
The Trump administration has been mum in recent weeks on its “most favored nation” drug pricing plan, which broadly aims to link U.S. prices for medicines to the lowest prices in other developed countries. It’s unclear what those prices will be, how they’ll be determined, or how the administration will ...
A Promising New AIDS Drug Highlights The Dangers Of Price Controls
The U.S. Food and Drug Administration approved a shot last month that effectively prevents HIV. At-risk people simply need to receive the injection every six months. The new drug, called lenacapavir, comes almost exactly 44 years after the first case of AIDS was reported by what’s now known as the ...
Let the Message Be Clear: Canadian Healthcare Failed
Meet Mary, a 60-year-old woman from British Columbia. She needed a colonoscopy to confirm her cancer diagnosis. Mary spent four months on a waiting list. Then her bowel ruptured, and she suffered life-threatening sepsis. Due to the delay in treating her cancer, she had to get chemotherapy, which came with ...
Trump tackles waste, fraud, and abuse in Obamacare
The Trump administration earlier this month finalized a rule that aims to stop waste, fraud, and abuse in the federally subsidized Obamacare exchanges. It’s about time. Millions of people who don’t qualify for free health coverage are receiving it on the public’s dime. The new rule will restore some measure ...
Democrats Should Be Honest About Healthcare Waste and Fraud
For weeks, opponents of Republicans’ One Big Beautiful Bill Act have portrayed it as a threat to health coverage for millions of Americans. Some critics have said that it would covertly repeal Obamacare. If only. The bill is hardly a radical assault on health coverage. It would finally crack down ...
Congress Can Help Small Businesses Afford Health Insurance
Health insurance is more expensive than ever. The average family plan last year cost employers and employees over $19,000 and nearly $6,300 per year, respectively. That’s enough to buy a new car. Congressional Republicans’ budget reconciliation bill could help bring down those costs. Among other things, the One Big Beautiful ...
Physician-Assisted Suicide Is A Bigger Problem Than We Realize
Dovie Eisner was born with a rare genetic condition called nemaline myopathy. He requires a wheelchair and has a host of other health problems. Last year at one point, he stopped breathing, passed out on the street, and was taken to the emergency room. “I was alive—thanks to the determination ...
